[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654
Sort by:

Global Waterborne Architectural Coatings Market Size Forecast to 2028- Trends, Analysis and Outlook by Application (Residential, Commercial), Application (Interior, Exterior), and Geography

US$ 2,899.00

Key insights from the Global Waterborne Architectural Coatings Market-The Global Waterborne Architectural Coatings market is valued at $55 billion in 2020Interior is the dominant application of Waterb...

May 2020 80 pages

Global Waterborne Coatings Market Size Forecast to 2028- Trends, Analysis and Outlook by Type (Polyester-based, Acrylic, Alkyd, Epoxy, Epoxy Ester, Alkyds, Polyester, Styrene-butadiene Copolymer, Polyurethane, Polyvinyl Acetate, Others), Application (Architecture, Industrial, Automotive, Marine, others), and Geography

US$ 2,899.00

Key insights from the Global Waterborne Coatings Market-The Global Waterborne Coatings market is valued at $84 billion in 2020Acrylic is the dominant type of Waterborne Coatings Architecture is the la...

May 2020 80 pages

Global Waterproofing Chemicals Market Size Forecast to 2028- Trends, Analysis and Outlook by Application (Roofing, building, Landfills and tunnels, Walls, others), Product (Bitumen, Polymers), Raw Materials (Synthetic Waterproofing Chemicals, Natural Waterproofing Chemicals, Semi-synthetic Waterproofing Chemicals) and Geography

US$ 2,899.00

Key insights from the Global Waterproofing Chemicals Market-The Global Waterproofing Chemicals market is valued at $7 billion in 2020Roofing is the largest application for Waterproofing Chemicals worl...

May 2020 80 pages

Global Wood Adhesives Market Size Forecast to 2028- Trends, Analysis and Outlook by Application (Flooring and Plywood, Furniture, Windows and Doors, Others), Product (Urea-formaldehyde, melamine-ureaformaldehyde, phenol-formaldehyde, Isocyanates, Others), and Geography

US$ 2,899.00

Key insights from the Global Wood Adhesives Market-The Global Wood Adhesives market is valued at $4.3 billion in 2020Flooring and Plywood is the largest application for Wood Adhesives worldwideAsia Pa...

May 2020 80 pages

Global Wood Coatings Market Size Forecast to 2028- Trends, Analysis and Outlook by Application (Solvent-borne coatings, Water-borne coatings, Radiation cured coatings, Powder coatings), Application (Furniture, Decking, Joinery, Siding, Flooring, Others), and Geography

US$ 2,899.00

Key insights from the Global Wood Coatings Market-The Global Wood Coatings market is valued at $11 billion in 2020Solvent-borne coatings is the dominant type of Wood Coatings Furniture is the largest...

May 2020 80 pages

Global Xylitol Market Size Forecast to 2028- Trends, Analysis and Outlook by Application (Chewing gum, Confectionery, Pharmaceutical, personal care, others), and Geography

US$ 2,899.00

Key insights from the Global Xylitol Market-The Global Xylitol market is valued at $1.2 billion in 2020Chewing Gum is the largest application for Xylitol worldwideEurope is the largest market for Xyli...

May 2020 80 pages

Global Yacht Coatings Market Size Forecast to 2028- Trends, Analysis and Outlook by Type (Epoxy, Polyurethane, Ethyl silicate, others), Application (Anti-Fouling, Fillers, Primers, Finishes, Others), and Geography

US$ 2,899.00

Key insights from the Global Yacht Coatings Market-The Global Yacht Coatings market is valued at $4 billion in 2020Epoxy coatings is the dominant type of Yacht coatings Anti-Fouling is the largest app...

May 2020 80 pages

COVID 19 Drug and Vaccine Pipeline Current Status Report: May 2020 Update

US$ 2,899.00

The May 2020 updated COVID-19 pipeline report presents most recent updates on drug candidates and vaccine candidates that will potentially reach the market in the next 2 years. As of May 2020, the CO...

May 2020 137 pages

2020 COVID 19 Drug Pipeline Report- Current Status, Phase, Companies, Pre-Clinical And Clinical Drugs

US$ 2,899.00

The 2020 COVID-19 pipeline report presents a comprehensive overview of the research and development of COVID drug candidates. It presents drugs in development that could potentially reach the market i...

March 2020 80 pages

2020 Alcohol Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Alcohol Addiction pipeline report presents a comprehensive overview of the research and development of Alcohol Addiction drug candidates. It presents drugs in development that could potential...

February 2020 133 pages

2020 Anesthetic Effect Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Anesthetic Effect pipeline report presents a comprehensive overview of the research and development of Anesthetic Effect drug candidates. It presents drugs in development that could potential...

February 2020 88 pages

2020 Attention Deficit Hyperactivity Disorder (ADHD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Attention Deficit Hyperactivity Disorder (ADHD) pipeline report presents a comprehensive overview of the research and development of Attention Deficit Hyperactivity Disorder (ADHD) drug candi...

February 2020 155 pages

2020 Autism spectrum disorders (ASD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Autism spectrum disorders (ASD) pipeline report presents a comprehensive overview of the research and development of Autism spectrum disorders (ASD) drug candidates. It presents drugs in deve...

February 2020 127 pages

2020 Batten Disease Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Batten Disease pipeline report presents a comprehensive overview of the research and development of Batten Disease drug candidates. It presents drugs in development that could potentially rea...

February 2020 82 pages

2020 Binge Eating Disorder Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Binge Eating Disorder pipeline report presents a comprehensive overview of the research and development of Binge Eating Disorder drug candidates. It presents drugs in development that could p...

February 2020 55 pages

2020 Canavan Disease Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Canavan Disease pipeline report presents a comprehensive overview of the research and development of Canavan Disease drug candidates. It presents drugs in development that could potentially r...

February 2020 31 pages

2020 Cancer Pain Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Cancer Pain pipeline report presents a comprehensive overview of the research and development of Cancer Pain drug candidates. It presents drugs in development that could potentially reach the...

February 2020 132 pages

2020 Cerebral Palsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Cerebral Palsy pipeline report presents a comprehensive overview of the research and development of Cerebral Palsy drug candidates. It presents drugs in development that could potentially rea...

February 2020 46 pages

2020 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) pipeline report presents a comprehensive overview of the research and development of Chronic Inflammatory Demyelinating Polyneuropathy...

February 2020 51 pages

2020 Cluster Headache Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Cluster Headache pipeline report presents a comprehensive overview of the research and development of Cluster Headache drug candidates. It presents drugs in development that could potentially...

February 2020 42 pages

2020 Cognitive Impairment Associated With Schizophrenia (CIAS) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline report presents a comprehensive overview of the research and development of Cognitive Impairment Associated With Schizophren...

February 2020 87 pages

2020 Complex Regional Pain Syndrome (Reflex Sympathetic Dystrophy) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Complex Regional Pain Syndrome (Reflex Sympathetic Dystrophy) pipeline report presents a comprehensive overview of the research and development of Complex Regional Pain Syndrome (Reflex Sympa...

February 2020 51 pages

2020 Dental Pain Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Dental Pain pipeline report presents a comprehensive overview of the research and development of Dental Pain drug candidates. It presents drugs in development that could potentially reach the...

February 2020 36 pages

2020 Drug Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Drug Addiction pipeline report presents a comprehensive overview of the research and development of Drug Addiction drug candidates. It presents drugs in development that could potentially rea...

February 2020 169 pages

2020 Encephalitis Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Encephalitis pipeline report presents a comprehensive overview of the research and development of Encephalitis drug candidates. It presents drugs in development that could potentially reach t...

February 2020 47 pages

2020 Encephalomyelitis Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Encephalomyelitis pipeline report presents a comprehensive overview of the research and development of Encephalomyelitis drug candidates. It presents drugs in development that could potential...

February 2020 51 pages

2020 Fatigue Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Fatigue pipeline report presents a comprehensive overview of the research and development of Fatigue drug candidates. It presents drugs in development that could potentially reach the market...

February 2020 42 pages

2020 Fibromyalgia Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Fibromyalgia pipeline report presents a comprehensive overview of the research and development of Fibromyalgia drug candidates. It presents drugs in development that could potentially reach t...

February 2020 76 pages

2020 Friedreich Ataxia Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Friedreich Ataxia pipeline report presents a comprehensive overview of the research and development of Friedreich Ataxia drug candidates. It presents drugs in development that could potential...

February 2020 102 pages

2020 Globoid Cell Leukodystrophy (Krabbe Disease) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Globoid Cell Leukodystrophy (Krabbe Disease) pipeline report presents a comprehensive overview of the research and development of Globoid Cell Leukodystrophy (Krabbe Disease) drug candidates....

February 2020 52 pages

2020 Guillain-Barre Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Guillain-Barre Syndrome pipeline report presents a comprehensive overview of the research and development of Guillain-Barre Syndrome drug candidates. It presents drugs in development that cou...

February 2020 46 pages

2020 Hyperalgesia Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Hyperalgesia pipeline report presents a comprehensive overview of the research and development of Hyperalgesia drug candidates. It presents drugs in development that could potentially reach t...

February 2020 34 pages

2020 Insomnia (Sleep Deprivation) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Insomnia (Sleep Deprivation) pipeline report presents a comprehensive overview of the research and development of Insomnia (Sleep Deprivation) drug candidates. It presents drugs in developmen...

February 2020 107 pages

2020 Interstitial Cystitis (Painful Bladder Syndrome) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Interstitial Cystitis (Painful Bladder Syndrome) pipeline report presents a comprehensive overview of the research and development of Interstitial Cystitis (Painful Bladder Syndrome) drug can...

February 2020 71 pages

2020 Low Back Pain Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Low Back Pain pipeline report presents a comprehensive overview of the research and development of Low Back Pain drug candidates. It presents drugs in development that could potentially reach...

February 2020 104 pages

2020 Metachromatic Leukodystrophy (MLD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Metachromatic Leukodystrophy (MLD) pipeline report presents a comprehensive overview of the research and development of Metachromatic Leukodystrophy (MLD) drug candidates. It presents drugs i...

February 2020 54 pages

2020 Mild Cognitive Impairment (MCI) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Mild Cognitive Impairment (MCI) pipeline report presents a comprehensive overview of the research and development of Mild Cognitive Impairment (MCI) drug candidates. It presents drugs in deve...

February 2020 94 pages

2020 Multiple System Atrophy (MSA) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Multiple System Atrophy (MSA) pipeline report presents a comprehensive overview of the research and development of Multiple System Atrophy (MSA) drug candidates. It presents drugs in developm...

February 2020 78 pages

2020 Narcolepsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Narcolepsy pipeline report presents a comprehensive overview of the research and development of Narcolepsy drug candidates. It presents drugs in development that could potentially reach the m...

February 2020 82 pages

2020 Neuromyelitis Optica (Devic's Syndrome) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Neuromyelitis Optica (Devic's Syndrome) pipeline report presents a comprehensive overview of the research and development of Neuromyelitis Optica (Devic's Syndrome) drug candidates. It presen...

February 2020 112 pages

2020 Nicotine Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Nicotine Addiction pipeline report presents a comprehensive overview of the research and development of Nicotine Addiction drug candidates. It presents drugs in development that could potenti...

February 2020 78 pages

2020 Obsessive Compulsive Disorder (OCD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Obsessive Compulsive Disorder (OCD) pipeline report presents a comprehensive overview of the research and development of Obsessive Compulsive Disorder (OCD) drug candidates. It presents drugs...

February 2020 51 pages

2020 Opioid Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Opioid Addiction pipeline report presents a comprehensive overview of the research and development of Opioid Addiction drug candidates. It presents drugs in development that could potentially...

February 2020 132 pages

2020 Post-Traumatic Stress Disorder (PTSD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Post-Traumatic Stress Disorder (PTSD) pipeline report presents a comprehensive overview of the research and development of Post-Traumatic Stress Disorder (PTSD) drug candidates. It presents d...

February 2020 133 pages

2020 Progressive Supranuclear Palsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Progressive Supranuclear Palsy pipeline report presents a comprehensive overview of the research and development of Progressive Supranuclear Palsy drug candidates. It presents drugs in develo...

February 2020 82 pages

2020 Restless Legs Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Restless Legs Syndrome pipeline report presents a comprehensive overview of the research and development of Restless Legs Syndrome drug candidates. It presents drugs in development that could...

February 2020 56 pages

2020 Rett Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Rett Syndrome pipeline report presents a comprehensive overview of the research and development of Rett Syndrome drug candidates. It presents drugs in development that could potentially reach...

February 2020 106 pages

2020 Sedation Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Sedation pipeline report presents a comprehensive overview of the research and development of Sedation drug candidates. It presents drugs in development that could potentially reach the marke...

February 2020 46 pages

2020 Spinal Muscular Atrophy (SMA) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Spinal Muscular Atrophy (SMA) pipeline report presents a comprehensive overview of the research and development of Spinal Muscular Atrophy (SMA) drug candidates. It presents drugs in developm...

February 2020 116 pages

2020 Tourette Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,999.00

The 2020 Tourette Syndrome pipeline report presents a comprehensive overview of the research and development of Tourette Syndrome drug candidates. It presents drugs in development that could potential...

February 2020 56 pages

Filters

Search

Categories

12,968
1,223
4,429
2
1
8,271
2,818
15,138
67
8,921
1
1,229
586

Publishers

55,654

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
55,617

Price

Date

Pages

Offers